Botanical pesticides, natural pesticides that are derived from plants, and notably essential oils (EOs), represent a potentially effective, eco-friendly, and safe alternative to conventional pesticides. This study evaluated in airtight glass chambers the effect of EOs from different boreal forest plants on Botrytis cinerea mycelial growth and on the development of tomato gray mold, a disease caused by B. cinerea. EO vapors from Labrador tea, black spruce, jack pine and, to a lesser extent, from sweet gale and balsam poplar were shown at a concentration of 200 µL/L of air to significantly reduce B. cinerea mycelial growth. At concentrations varying from 20 to 200 µL/L of air, EO vapors from Labrador tea, black spruce, and jack pine significantly influenced B. cinerea growth kinetics in a dose-dependent manner. Mycelial growth of B. cinerea was strongly delayed in the presence of vapors of either EO at concentrations of 100, 150, and 200 µL/L of air. Exposure of tomato fruits to the vapors of tested EOs at 50 µL/L of air was shown to significantly inhibit the development of gray mold. EO from Labrador tea was particularly effective by completely inhibiting (during the exposure period) the development of the disease when applied at a concentration of 100 µL/L of air. GC-MS analyses revealed that the main compound present in the vapors produced by the EOs from black spruce, Labrador tea, and jack pine was α-pinene (42%), sabinene (59%), and α-pinene (79%), respectively. This study suggests for the first time the possibility of using EOs from boreal forest plants as botanical pesticides to repress B. cinerea mycelial growth and to control tomato gray mold.
Plant-derived products, particularly essential oils, represent a promising source of antiviral scaffolds. Although Populus balsamifera L. has been traditionally used to manage respiratory ailments and infections, the antiviral potential of its bud essential oil remains unexplored. In this study, we evaluated the in vitro antiviral cytoprotective activity of P. balsamifera bud essential oil and its major constituents against HCoV-OC43, a human betacoronavirus associated with seasonal respiratory infections, using a cell-based cytoprotection assay. The assay reliably detected the activity of reference antivirals, including chloroquine (EC50 = 0.11 ± 0.01 µg/mL), molnupiravir, and fluvoxamine, supporting its suitability for antiviral screening. Under these conditions, P. balsamifera bud essential oil exhibited strong cytoprotective activity, with an EC50 of 3.3 ± 0.5 µg/mL. Chemical analysis revealed a sesquiterpene-rich composition. Two major constituents, α-bisabolol and nerolidol, also showed marked cytoprotection, with EC50 values of 2.7 ± 0.3 µg/mL and 2.6 ± 0.4 µg/mL, respectively, supporting their contribution to the overall activity of the oil. To our knowledge, this study provides the first experimental evidence of antiviral cytoprotective activity of P. balsamifera bud essential oil against a human coronavirus and identifies α-bisabolol and nerolidol as active compounds in this model.
The antibacterial constituents of Rhus typhina drupes remain poorly characterized despite their traditional medicinal use to treat infections. The methanolic extract of R. typhina drupes was evaluated for its antibacterial activity. It inhibited Escherichia coli (IC50 = 12 ± 1 µg/mL) and Staphylococcus aureus (IC50 = 33 ± 8 µg/mL). The extract was subjected to partial bioassay-guided fractionation and phytochemical investigation, leading to the isolation of eighteen compounds whose structures were elucidated by mass spectrometry and nuclear magnetic resonance spectroscopy. A new lupane-type triterpenoid, 3α-hydroxy-3β,25-epoxylup-20(29)-ene (1), was identified and characterized by high-resolution mass spectrometry, IR spectroscopy, and detailed 1D and 2D NMR analyses. HMBC and NOESY correlations supported a lupane-type skeleton bearing a ring-A hemiketal functionality and established its relative stereochemistry. Antibacterial activity was assessed against E. coli and S. aureus for the six isolated compounds available in sufficient quantities for testing. Compound 1 showed activity against S. aureus (IC50 of 0.052 ± 0.004 µM), while its cytotoxicity IC50 toward human WS-1 fibroblasts was >100 µM. Hyperoside (16) was also active against S. aureus (IC50 of 0.48 ± 0.09 µM). These results identify compound 1 as a candidate for further investigation of its antibacterial properties.